The European Union warned Wednesday of a wave of antitrust investigations into major drug makers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire. "Makers of original medicines are actively trying to delay the entry of generic medicines onto their markets," EU Competition Commissioner Neelie Kroes said. She said regulators knew of at least 200 settlement agreements between generic and major drug makers.
July 09, 2009 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The European Union warned Wednesday of a wave of antitrust investigations into major drug makers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire.
“Makers of original medicines are actively trying to delay the entry of generic medicines onto their markets,” EU Competition Commissioner Neelie Kroes said.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
